Adverse effects following COVID-19 vaccination in Iran

• Published in: BMC infectious diseases Vol. 22; no. 1; pp. 476 - 8
• Main Authors: Babaee, Ebrahim, Amirkafi, Ali, Tehrani-Banihashemi, Arash, SoleimanvandiAzar, Neda, Eshrati, Babak, Rampisheh, Zahra, Asadi-Aliabadi, Mehran, Nojomi, Marzieh
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.05.2022; BioMed Central; BMC
• Subjects: Adverse and side effects; Adverse effect; AstraZeneca; Chi-square test; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - adverse effects; Demographic variables; Drug dosages; Drug-Related Side Effects and Adverse Reactions - epidemiology; Drugs; Fever; Headaches; Health services; Humans; Infections; Iran - epidemiology; Pain; Questionnaires; Random sampling; Retrospective Studies; SARS-CoV-2; Side effects; Sinopharm; Sputnik V; Statistical sampling; Statistical tests; Statistics; Vaccination - adverse effects; Vaccine; Vaccines; Iran; COVID-19; Sinopharm; Iran; Sputnik V; Vaccine; AstraZeneca; Adverse effect

Vaccination is a key intervention to prevent COVID-19. Many vaccines are administered globally, yet there is not much evidence regarding their safety and adverse effects. Iran also faces this challenge, especially as data regarding the Sputnik V vaccine is sparse. Therefore, the aim of this study is...